Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

BACKGROUND: This retrospective study aims to assess the usefulness of SUV(max) from FDG-PET imaging as a prognosticator for primary biopsy-proven stage I NSCLC treated with SBRT. METHODS: This study includes 95 patients of median age 77 years, with primary, biopsy-confirmed peripheral stage IA/IB NS...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Horne, Zachary D, Clump, David A, Vargo, John A, Shah, Samir, Beriwal, Sushil, Burton, Steven A, Quinn, Annette E, Schuchert, Matthew J, Landreneau, Rodney J, Christie, Neil A, Luketich, James D, Heron, Dwight E
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2014
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922961/
https://ncbi.nlm.nih.gov/pubmed/24479954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-9-41
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन